Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Doctors Perform Breakthrough Liver Cancer Treatment

Breakthrough Liver Cancer Treatment
For the first time in Israel, surgeons at Sheba Medical Center performed a cutting-edge procedure on a patient with liver cancer. They extracted a cancer-infected liver from a patient, removed the tumor, and then performed a healthy liver transplant back into the patient’s body.

Worldwide, this advanced surgery has only been done on approximately 100 patients. In Israel, Prof. Daniel Azoulay performed the procedure, working in collaboration with Dr. Elon Lahat and a comprehensive team of medical specialists, including anesthesiologists, surgeons, nurses, and technicians.

A few years ago, the patient, a woman in her thirties, was diagnosed in Brazil with colon cancer. Upon her immigration to Israel, doctors examined her and diagnosed a metastasis of about 15 cm to the liver. They designed a treatment program that involved delivering chemotherapy immediately, followed by progressive surgery.

The operation was done as a three-part process. First, surgeons excised the liver from the body and immersed it in sterile ice with a temperature of 4 ° C. Then, they cut out the cancerous tumor while the liver remained iced. In the final stage, the healthy liver was transplanted back into the patient.

“This is one of the most complex liver surgeries in the world,” said Prof. Azoulay. “It involves the integration of liver surgery – which is always complicated – and a liver transplant. This surgery poses many serious risks, including potentially fatal bleeding. However, to our great pleasure, the patient survived, and we hope to send her home within 10 days.”

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More